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wound infection in head and neck squamous
cell carcinoma surgery with opening of
mucosa. Study of 260 surgical proceduresNicolas Penela,b,*, Charles Fournierb,c, Danie`le Lefebvred,
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e Head and Neck Department, Centre Oscar Lambret, 3, rue F Combemale, 59020 Lille, FranceReceived 10 August 2004; accepted 27 August 2004Summary The goal of this prospective study was to determine risk factors for
wound infections (WI) for patients with Head and Neck cancer who had undergone
surgical procedures with opening of upper aerodigestive tract mucosa in multimodal
therapeutic approaches.
Two hundred and sixty consecutive surgical procedures were studied at Oscar
Lambret Cancer Center over a 36-month period. Twenty-five variables were re-
corded for each patient. Statistical evaluation used v2 test analysis (categorical
data) and Mann–Whitney test (continuous variables). Multivariate analysis was per-
formed with logistic regression model.
The overall rate of WI was 45% (117/260). Univariate analysis indicated that five
variables were significantly related to the likelihood of WI: male sex (p = 0.03),
previous chemotherapy (p = 0.009), duration of previous hospital stay (p = 0.013),
hypopharyngeal location (p = 0.003), post-laryngectomy tracheostoma (p < 0.001).
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36 N. Penel et al.Multivariate analysis identified only one major risk factor for WI: post-laryngectomy
tracheostoma (odd ratio 1.9 [95% CI 1.3–3]; 33% versus 64%; p = 0.001).
Despite antibiotic prophylaxis, WI occurrence is high. This study identified one
major risk factor. Long-term curative antibiotherapy must be evaluated in cancer
head and neck surgery requiring post-laryngectomy tracheostoma.c 2004 Elsevier Ltd. All rights reserved.Introduction
The incidence of wound infections (WI) in clean
contaminated head and neck cancer surgery with-
out administration of preoperative antibiotic
ranges from 30% to 80%.1 These procedures requir-
ing entry into the mucosa of the respiratory or
digestive tracts expose the surgical wound to oro-
pharyngeal secretions and bacteria.2 WI may have
an adverse prognosis,3 leads to significant morbid-
ity, poor cosmetic results, prolonged hospitaliza-
tion,1,4–6 sometimes, even death, and delayed
wound healing and, therefore, may delay postoper-
ative radiotherapy.
With antibiotic prophylaxis, the risk of postoper-
ative WI has been dramatically reduced.1,7 Antibi-
otic prophylaxis must cover a large bacterial
spectrum made up of aerobes and anaerobes of
oropharyngeal saprophytic flora, and the need for
Gram negative coverage has been discussed.7
Short-term antibiotic prophylaxis (24 or 48h) is as
efficient as long-term.8–12 But, despite adequate
antibiotic prophylaxis, WI is reported in up to 40%
of procedures.1,7
The initial step to prevent surgical WI is to iden-
tify the high-risk factors. Altemeier’s contamina-
tion class, duration of surgery, the patient’s
American Society of Anesthesiology Score (ASA),
and National Nosocomial Infections Surveillance
System (NNISS) are known to influence the likeli-
hood of postoperative sepsis. However, head and
neck cancer patients carry a high risk both for sur-
gery and anesthesia due to coexisting medical con-
ditions and a frequent preoperative debilitate
physical state.13,14 Moreover, numerous factors
specific to head and neck cancer surgery could play
a role in the occurrence of infection: preoperative
tracheotomy,15,16 previous radiotherapy,17,18 flap
reconstruction of the surgical defect.9,15
These factors have not been found to be signifi-
cant in all studies,1,9,15–18 and therefore remain
controversial as regard their potential impact onWI.
In order to establish risk factors associated with
postoperative WI, a prospective study was con-
ducted from January 1997 to December 1999 in
the Head and Neck Department of Oscar LambretCancer Center. A preliminary report including 165
surgical procedures was previously published.1Patients and methods
Twohundred and sixty consecutive clean contam-
inated procedures for biopsy-confirmed squamous
cell carcinoma of the upper aerodigestive tract (oral
cavity or oropharynx in 137 cases, larynx in 53 cases
or hypopharynx in 69 cases) were prospectively ana-
lyzed for predictive factors for WI. All procedures
wereperformedbetweenJanuary1997andDecember
1999 at the Head and Neck Cancer Center.
Only procedures that involved a neck wound in
communication with oral cavity or pharynx were in-
cluded. Transoral resections, isolated tracheoto-
mies, surgical procedures for benign tumors or for
cell types other than squamous cell carcinoma
were excluded from this study. In all cases, surgery
was performed with curative intent.
Surgical procedures were performed while
observing the general rules of sterility. All wounds
were prepared with povidine-iodine and irrigated
with normal saline before closure. In all cases, pro-
phylactic antibiotic therapy was administrated on
induction of anesthesia and pursued for 48h.
Between January 1997 and December 1998, all
ncluded patients (165) received clindamycin (ini-
tially 900mg I.V., and 600mg every 8h during
48h) and netromycin (3mg/kg I.V. one time).
Between January 1999 and December 1999,
according to modification of French Recommenda-
tions about Antibiotic prophylaxis,1 the patients
received Amoxicillin and Clavulanic acid (initially
1g I.V., and 1g every 8h during 48h).
Twenty-five parameters were recorded for each
patient. Those included patient characteristics
(sex, age, weight, body mass index, weight loss,
ASA score, tabacco and alcohol history, dental sta-
tus, neutrophil count, albumin level, prealbumin
level, . . .), disease characteristics (pretreated or
not pretreated cancer, location, TNM stage), previ-
ous treatment (previous surgery, previous chemo-
therapy, previous radiotherapy), present surgical
procedure (method of reconstruction, tracheotomy
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associated, length of surgery, identification of sur-
geon) and wound characteristics.
For each patient, we considered overall preop-
erative hospital stay within the year prior to the
surgery. Patients are hospitalized for the prethera-
peutic workup, including physical, nutritional, and
psychosocial evaluation, panendoscopy under gen-
eral anesthesia with biopsies, and imaging. In
Northern France, because of the particular profile
of head and neck squamous cell carcinoma, this
workup is rarely feasible in an outpatient manner.
Postoperative wounds were evaluated daily and
monitored until the end of postoperative hospital
stay. According to the criteria described by John-
son et al.,9 WI were defined as the presence of
purulent drainage from the wound, or as the pres-
ence of an orocutaneous or pharyngocutaneous fis-
tula regardless of etiology (including flap failure).
Samples for aerobic and anaerobic cultures were
collected from the infected wounds. Organisms
were identified using conventional taxonomic
schemes.
Statistical evaluation was performed using v2
test and Yates corrected v2 analysis for categorical
data and Mann–Whitney test in most instances for
continuous variables. The multivariate analysis
used a logistic regression model in which including
significant risk factor in univariate analysis. The le-
vel of significance was set at 5% (p < 0.05).Table 1 Surgical procedures
Location Number Surgical
Oral cavity
Oropharynx
51.9%
(137/260)
64 resec
6 total g
6 partial
3 hemi-m
4 maxill
4 resect
14 segm
34 marg
2 extend
Hypopharynx 26.1%
(69/260)
45 laryn
14 laryn
6 lateral
4 extend
Larynx 19.2%
(53/260)
22 total
27 partia
4 extendResults
The study consisted of 260 surgical procedures
with curative intent for biopsy-proven squamous
cell carcinoma of the upper aerodigestive tract
(Tables 1 and 2).
The mean patient age was 57.1years (range,
35.8–83.0). There were 26 women. No patient
had neutropenia at the time of surgery. ASA score
was respectively 1 in 40 cases, 2 in 149 cases, 3
in 66 cases and 4 in 1 case. Sixty patients had poor
dental status.
The anatomic locations were 137 oral cavity or
oropharynx cancers, 53 larynx cancers and 69
hypopharynx cancers. Ninety-four patients had a
clinical nodal involvement. One hundred and
forty-two patients had T3 or T4 diseases.
Fifty patients had a previous cancer (27 previous
squamous cell carcinoma of upper aerodigestive
tract, 11 esophagus cancers, 2 colon cancers, 2
bladder cancers, 1 hepatocarcinoma, 1 lung
cancer, 1 malignant melanoma, 1 Hodgkin lym-
phoma, 1 breast cancer, 1 thyroid cancer, 1 malig-
nant myeloma, 1 chronic lymphocytic leukemia).
Ninety-seven patients had recurrent squamous
cell carcinoma previously treated by radiotherapy
in 92 cases, by chemotherapy in 38 cases and by
surgery in 59 cases.
Most of patients (236 out of 260 patients) had
had previously hospitalized.procedures
tions with hemimandibulectomy or mandibular swing
lossectomies
glossectomies
andibulectomies
ectomies
ions without mandibulectomy
ental mandibulectomies
inal mandibulectomies
ed supraglottic laryngectomies
gectomies with partial pharyngectomy
gectomies with circumferential pharyngectomy
pharyngectomies
ed supraglottic laryngectomies
laryngectomies
l laryngectomies
ed supraglottic laryngectomies
38 N. Penel et al.Surgical procedures are presented in Table 1.
Neck dissections were performed in 198 cases. Sur-
gical procedures required a tracheotomy in 144
cases (mainly for oropharynx and oral cavity can-
cers) and generated a post-laryngectomy tracheo-
stoma in 90 cases (mainly for hypopharyngeal and
laryngeal cancers).Table 2 Relationship between patient characteristics and
Factor Percentage of data
not done
Ca
Sex 0 Ma
Fe
Previous cancer 0 Ye
No
Previous chemotherapy 0 Ye
No
Previous radiotherapy 0 Ye
No
Previous surgery
for cancer
0 Ye
No
Duration of total
preoperative stay (days)
2.6 >3
0–
ASA score 0.6 1
2
3
4
Surgeon 3.6 Su
Su
Su
Su
Su
Dental status 2.4 Ba
Go
Ed
T stagec 7.2 3
1
N-stage 7.2 N+
N
Primary site 1.8 Hy
La
Or
Carcinologic history 2.4 Pr
No
Neck dissection 1.2 Pe
No
Flap reconstruction 4.8 Pe
No
Post-laryngectomy
tracheostoma
6.6 Pe
No
Tracheotomy 6.6 Pe
No
aCases without wound infection.
bCases with wound infection.
cT status according to TNM classification.Primary closure was possible in 145 surgical pro-
cedures, whereas flap reconstruction was neces-
sary in 115 cases. Pectoralis major myocutaneous
flap was used in 89 cases. The duration of surgery
procedure averaged 3h78 [0h59–9h30].
One hundred and seventeen WI were recorded
during the study resulting in an overall rate of 45%.risk of wound infection (categorical data)
tegories No WI WI P (v2 test)
les 123 111 0.02
males 20 6
s 58 61 0.32
59 82
s 25 13 0.009
92 130
s 46 46 0.28
71 97
s 25 34 0.81
14 10
93 59 0.013
3 33 47
26 14 0.18
83 66
31 35
1 0
rgeon A 16 25 0.21
rgeon B 17 9
rgeon C 29 20
rgeon D 47 38
rgeon E 30 22
d 27 18 0.14
od 10 3
entulation 70 72
+ 4 70 72 0.06
+ 2 60 36
51 40 0.94
81 67
popharynx 26 44 0.003
rynx 30 23
al cavity 85 51
etreated cancer 49 48 0.22
pretreated 65 94
rformed 10 89 0.99
t performed 9 27
33
rformed 57 58 0.14
t performed 81 58
rformed 32 58 <0.001
t performed 10 52
4
rformed 90 54 0.015
t performed 48 56
Table 3 Relationship between patient characteristics and risk of wound infections (continuous variables)
Parameter (unit) Percentage of data
not done
Mean and standard
deviation in cases
without WI
Mean and standard
deviation in cases
with WI
p*
Age (years) 0 58.0 (11.4) 56.4 (0.1) 0.19
Body mass index (kg/m2) 3.5 23.1 (4.6) 22.8 (4.2) 0.44
Weight loss (kg) 38.1 3.7 (5.5) 3.1 (4.6) 0.92
Prealbumine level (%) 60.4 85.0 (22.7) 87.1 (27.2) 0.69
Albumine level (%) 55 87.7 (16.7) 88.2 (15.8) 0.94
Duration of surgical procedure (hour) 8.1 3.66 (1.69) 3.90 (1.87) 0.44
Neutrophil count (/mm3) 3.1 6026 (2914) 6919 (3760) 0.8
Alcohol consumption (g/week) 40.8 500 (722) 439 (382) 0.66
Tobacco history (pack-year) 17.3 48 (26) 49 (25) 0.59
* Mann–Whitney test performed.
Table 4 Risk factors for wound infections: multivariate analysis
Parameter WI rate
if absent
WI rate
if present
Odds ratio
[95% CI]
Univariate
analysis
Multivariate
analysis
Male sex 23.1% 47.4% 2.04 [1.2–3.9] 0.03 0.08
Previous chemotherapy 41.4% 65.8% 1.58 [1.05–2.8] 0.009 0.42
Previous hospital stay 41.7% 45.3% 1.1 [1.02–1.8] 0.013 0.12
Hypopharyngeal location 38% 63.2% 1.65 [1.52–2.6] 0.003 0.78
Laryngectomy stoma 33.3% 64.4% 1.9 [1.3–3.3] <0.001 0.001
Wound infection in major head and neck cancer surgery 39WI rates were similar with the two different antibi-
otic prophylaxis regimen (p = 0.17). WI were: puru-
lent discharge in 44 cases, fistula in 27 cases and
association of purulent discharge and fistula in 46
cases. Patients without WI had a median postopera-
tive hospital stay of 19days (range, 3–64days), in
comparison with 35days (range, 12–178days) for
those who were infected (p = 0.00002).
Postoperative wound cultures revealed potential
pathogens in 109 cases. In most cases, cultures
were polymicrobial. The main causative agents
were: Escherichia coli (28 cases), coagulase nega-
tive Staphylococcus (18 cases), non-hemolytic
Streptococcus (16 cases) and Staphylococcus aur-
eus (11 cases). Overall, 45% were aerobes Gram
negative rods, 40% were aerobes Gram positive
cocci and 15% were anaerobes.
Univariate analysis (Tables 2 and 3) identified
five factors to significantly alter the incidence of
WI (Tables 2 and 3): male gender (p = 0.003), previ-
ous chemotherapy (p = 0.009), duration of previous
hospital stay (p = 0.013) hypopharyngeal location
(p = 0.003) and post-laryngectomy stoma (p = 1 
105).
In multivariate analysis (Table 4), only one
major risk factor was identified: post-laryngectmytracheostoma p = 0.01, WI rate of 64% with laryng-
ectomy stoma and WI rate of 33% without laryngec-
tomy stoma, odd ratio 1.9 [95% IC 1.3–3].Discussion
The incidence of WI in head and neck cancer sur-
gery with opening of upper aerodigestive tract mu-
cosa is very high. In our study, WI occurrence is
45%. But, our patients had often T3 and T4 disease
(54%), had invasive squamous cell carcinoma in all
cases, had had previous history of cancer in 45%
of cases, and had recurrent cancer in 37% of cases.
These conditions are very unfavorable. However,
other recent studies, with the same definition of
WI (including fistula) found similar rates of 22–
47%.9,12,17,19
In our study, most of parameters recorded were
not related to WI. No previous study found that age
or ASA score could increase WI rates in head and
neck cancer surgery. In our study we didn’t find
any link between nutritional parameters and WI.
Unlike our study, Cole et al. noted a tendency to-
ward infection in patients with tobacco history.20
Table 5 Risk factors for WI in head and neck cancer surgery with opening of upper aerodigestive tract: results of five multiparametric studies
Authors
Girod et al. Pelczar et al. Cole et al. Robbins et al. Present study
Reference 17 23 20 16 –
Period of study 1985–91 1990 1985 1990 1997–99
Type of study Retrospective/
multicenter
Prospective/
single center
Prospective/
single center
Prospective/
multicenter
Prospective/single center
Length of study 72months 18months 11months ND 36months
Type of surgical
procedure
Surgical procedures
exceeding 2h
Class II surgical
procedures
123 class I a
surgical procedures
268 class II a
surgical procedures
33 class III a
surgical procedures
Only surgical procedures
with opening of the UADT
b mucosa for biopsy-proven
squamous cell carcinoma
Total number 159 119 59 400 260
Oral cavity and
Oropharynx
87 32 42 191 137
Larynx 32 30 11 52 53
Hypopharynx 37 14 6 22 69
Definition of WI Johnson’s criteria ND Johnson’s criteria Johnson’s criteria Johnson’s criteria
Squamous cell
carcinoma
156/159 ND 59/59 263/400 260/260
Mean age 60.2 [21–85] 64 [38–84] ND ND 57.1 [36–83]
T3 and T4c 124/150 49/119 27/59 ND 142/260
Previous chemotherapy 17/159 (10%) ND 1/59 (1.6%) 34/400 (8.5%) 38/260 (6.8%)
Previous radiotherapy 62/159 (38%) ND 22/59 (37%) 117/400 (29%) 92/260 (35%)
Previously treated cancer 63/159 (39%) ND ND ND 97/260 (37%)
ASA 3 and 4d ND 71/119 (59%) ND ND 68/260 (26%)
Flap reconstruction 84/159 (52%) ND 22/59 (37%) 108/400 (27%) 115/260 (44%)
Antibiotic prophylaxis Clindamycin and
Gentamycin
or Ampicillin and
sulbactam
ND Cefazolin Cefazolin alone
or metronidazol
and cefazolin
Clindamycin- Gentamycin or
Amoxicillin-acid clavulanic
WIe 35/159 (22%) ND 15/59 (25.4%) 63/400 (19.75%) 117/260 (45%)
WI rate for oral cavity
and oropharynx cancers
ND ND 10/42 (23.8%) /191 (38.5%) 51/137 (37.8%)
WI rate for larynx cancers ND ND 18% (2/11) 21% (11/52) 23/53 (44.2%)
Rate of WIS for hypopharynx
tumours
ND ND 50% (3/6) 21% (11/52) 43/69 (63.2.%)
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Risk factors in univariate
analysis
Previous
radiotherapy
 Platelet count
>400000/mm3
 Length of surgical
procedure
 Prolonged length
of pre-surgical
hospitalization
 T3/T4 stage
 Node extension
 Length of surgical
procedure
 Alte er class III
 T3/ tage
 Abse of
cove e for anaerobic
 Len of surgical
proc re
 Flap construction
 Tra sion
 Dra e
 Nas tric tube
 Eth
 Nod atus
 Com xity of procedure
 Male sex
 Previous
chemotherapy
 Previous
hospital stay
 Hypopharyngeal
location
 Post-laryngectomy
tracheostoma
Multivariate analysis of
risk factors
– –  T3/T4 stage
 Coexisting medical
pathology
 Node extension
 Abse of coverage
of a robic
 Nod tension
 Alte ier class III
 Laryngectomy stoma
ND = not done.
aAccording to Altemeier classification. b Upper aerodigestive tract. c Tumor extension according to TNM classification. d rican Society of Anesthesiology score. eOccurrence of
wound infections.
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42 N. Penel et al.Like Clayman et al. and Doerr and Marunick, we did
not find increased WI rates after preoperative
endentulation.21,22 Also, no significance was noted
in our study between WI and lymphocyte, neutro-
phil or platelet counts. On the contrary, Pelczar
et al. found high platelet count to be significantly
related to WI.23
In several studies16,20,24 but not in the present
study, tumor size was a significant risk factors for
WI. The large tumors often caused more pain and
alter deglutition leading to nutritional depletion.
Excision of extensive resulted in large defects and
subsequently in more complex reconstruction. Un-
like others,16,20 we did not find the node status to
be significantly related to WI.
No significance was noted between WI and previ-
ous radiotherapy in our study as well as in several
other studies.5,10,11,16,20,24–34
Several factors related to the surgical procedure
were associated with WI. In previous studies, dura-
tion of procedure was a risk factor.6,20,35 On the
contrary, we found no correlation between WI risk
and length of procedure. In several studies6,15,16
flap reconstruction, especially with major pecto-
ralis myocutaneous flap, was linked to WI.
In our experience, length of surgery and ASA
score did not correlate with risk for WI. Thus, to
our opinion, NNISS, which including length of sur-
gery and ASA score, had no utility for head and
neck cancer surgery with opening of upper aerodi-
gestive tract mucosa. As a result analysis of specific
risk factors appeared to be necessary.
In our univariate analysis, five parameters were
related to risk of WI: male sex, previous chemo-
therapy, previous hospitalization, hypopharyngeal
location and laryngectomy stoma.
Male sex was associated with risk of WI. No pre-
vious study found same results. But male patients
most often present (especially in Northern France)
more heavy comorbidities and both heavier alcohol
and tobacco addictions.36
In previous studies, a predilection to WI was ob-
served in oropharynx and oral cavity cancers.6,25
But, like Cole et al.,20 we found hypopharyngeal
location to be significantly related to WI. Hypopha-
ryngeal location is clearly associated with poor sur-
gical and anesthetic risk.36
Significance was noted in our study between WI
and chemotherapy. Previously Corey et al. had
found similar results.37 In our study, WI occurred
in 65% of patients with previous chemotherapy,
while incidence of WI in patients without previous
chemotherapy was 41.4% (p = 0.009). Anticancer
chemotherapy adversely affects number and func-
tions of neutrophil, macrophages (chemotaxis,
phagocytis, bactericial activity), B-cell and T-cell,resulting in diminished opsonizing activity, inade-
quate agglutination and lysis bacteria, and deficient
neutralization of bacterial toxins. Consequently,
patients with defects in cellular and humoral immu-
nity and antibody production have increased suscep-
tibility to pyogenic bacterial infections, even if they
are not neutropenic. In two previous studies, we
found that previous anticancer chemotherapy in-
creases WI rate in clean head and neck surgery38
and in clean breast cancer surgery.39
Like Weber et al.,40 we found a statistical corre-
lation between WI and previous hospitalization.
These previous hospitalizations certainly affect
the patient’s flora, with colonization by pathogens
with intrinsic resistance to antibiotics or with ac-
quired antibiotic resistance.
Clearly, potential risk factors are numerous and
previous multiparameter studies found very differ-
ent significant risk factors (Table 5). But these
studies are not comparable due to different WI def-
initions,23 or different patient characteristics.
Our multivariate analysis identified only one risk
factor for WI in squamous cell carcinoma surgery
with opening of mucosa: post-laryngectomy tra-
cheostoma. Two different causes can explain this
relation: infection on foreign body and the high
rate of WI after salvage laryngectomy following
failure of larynx preservation strategy.
We found like Cole et al.20 that the presence of a
post-laryngectomy tracheostoma increased risk of
WI. Presence of a post-laryngectomy tracheostoma
may lead to colonization of wound, because there
is a permanent communication between wound,
skin and the respiratory tract. As a result a post-
laryngectomy tracheostoma favors infection by
saprophytic flora of skin and the respiratory tract,
and favors the persistence of this infection, like
other infections on foreign body. On the contrary,
tracheotomy performed essentially for oral cavity
and oropharyngeal cancers is faraway from surgical
wound.1
Salvage laryngectomy following larynx preserva-
tion is associated with high rate of WI (Tables 1 and
4). All parameters significant in the present univa-
riate analysis were related to salvage laryngectomy
after failure of larynx preservation strategy (Table
4). Clearly, laryngectomy is associated with
hypopharyngeal and laryngeal locations. Duration
of previous hospitalization stay s associated with
chemotherapy administration (cisplatin and 5-
fluoro-uracil regimen requiring hospitalization41).
Hypopharyngeal and laryngeal cancers were most
frequent in male.
Despite antibiotic prophylaxis, WI occurrence in
head and neck cancer surgery with opening of upper
aerodigestive tract is reported as superior to
Wound infection in major head and neck cancer surgery 4320%.1,7,9,16,17,19,20,42 These surgical procedures do
not correspond to a clean-contaminated surgery,
but belong to contaminated surgery (Altemeier class
III). But several previous studies showed that short-
term antibiotic prophylaxis (24 or 48h) was as effi-
cient as long-term one. Identification of risk factor
for WI is necessary. Our study identifies a high-risk
population. Head and neck cancer surgical proce-
dures including laryngectomy stoma seem to be
contaminated or dirty procedures, that require anti-
biotic treatment and not antibiotic prophylaxis.
These results can help to better design future pro-
spective studies that will use new preventive strat-
egies like selective long-term antibiotherapy, or
new approaches like hematopoietic growth factor43
or preoperative enteral and/or parenteral nutrition
associated with antibiotherapy.44References
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